Baudax Bio Inc (BXRX) Return on Investment ROI from the third quarter of 2023 to third quarter of 2022 and for the year 2023, average high and low, overall ranking from Sep 30 2023 to Sep 30 2022 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Baudax Bio Inc   (NASDAQ: BXRX)


Baudax Bio Inc's ROI from its third quarter of 2023 to the third quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Baudax Bio Inc's ROI in the third quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Baudax Bio Inc 's return on investment (ROI) in its third quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter		 (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter
Y / Y Investment Change TTM - - - -83.34 % -61.87 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 2 1 -5 -11 -8
Return On Investment (TTM) 199.54 % 567.36 % - - -
BXRX's Overall Ranking # # # # #
Seq. Investment Change TTM - - - -58.89 % -39.96 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -7 -34 -35 -59 -23

BXRX Company Profile >> Back to BXRX Roi Comparisons >> See Annual BXRX Return On Investment



Return On Investment BXRX's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Baudax Bio Inc's III. Quarter Investments $ 2 Millions BXRX's Balance sheet
Baudax Bio Inc's III. Quarter Income $ -2 Millions Quarterly BXRX's Income Statement
BXRX's Income by Division See BXRX's Income by Division


BXRX Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019
Total Investments in Millions -11 38 51 47 0
Y / Y Investment Growth - -25.64 % 8.83 % - -
Net Income in Millions -59 -22 -76 -33 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -58.97 % -150.38 % -70.02 % -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
BXRX's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for BXRX's Competitors
Subscribers only: Roi for Baudax Bio Inc's Suppliers
Subscribers only: Return On Investment for BXRX's Customers

Other Ratios
BXRX's Roa BXRX's Inventory Turnover Ratio BXRX's Growth Rates BXRX's Dividend Statistics
BXRX's Profitability Ratios BXRX's Asset Turnover Ratio BXRX's Dividend Growth
BXRX's Roe BXRX's Valuation Ratios BXRX's Financial Strength Ratios BXRX's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2023, within Healthcare Sector ROI
Ir med Inc   300.96 %
Tff Pharmaceuticals Inc  241.72 %
Therapeuticsmd Inc   179.97 %
Inhibitor Therapeutics Inc   100.93 %
Glucotrack Inc   88.82 %
Scynexis Inc   79.06 %
Biomx Inc  76.77 %
Ladrx Corporation  74.45 %
Molecular Templates Inc   73.94 %
Avalo Therapeutics Inc   67.67 %
Opus Genetics Inc   65.54 %
Dariohealth Corp   57.65 %
Cv Sciences Inc   51.59 %
Elite Pharmaceuticals Inc   47.02 %
Gyre Therapeutics Inc   45.47 %
Star Equity Holdings Inc   44.42 %
Idexx Laboratories Inc  43.85 %
Entera Bio Ltd   41.70 %

Date modified: 2026-08-29T17:41:29+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.